Recombinant Human monoclonal antibody expressed in CHO binding to Ovr110. The antibodiess and antigen binding fragments directed against Ovr110 which is expressed by head and neck, ovarian, endometrial, kidney, pancreatic, lung or breast cancer are provided, are used for alleviating or treating an Ovr110-expressing cancer in a mammal.
This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:
• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production
See more details about Hi-Affi™ recombinant antibody benefits.
Download resources about recombinant antibody development and antibody engineering to boost your research.
CAT | Product Name | Application | Type |
---|---|---|---|
TAB-0870CL | Mouse Anti-Ovr110 Recombinant Antibody (TAB-0870CL) | IHC | Mouse IgG |
TAB-0870CL-S(P) | Mouse Anti-Ovr110 Recombinant Antibody; scFv Fragment (TAB-0870CL-S(P)) | IHC | Mouse scFv |
TAB-0870CL-F(E) | Mouse Anti-Ovr110 Recombinant Antibody; Fab Fragment (TAB-0870CL-F(E)) | IHC | Mouse Fab |
CAT | Product Name | Application | Type |
---|---|---|---|
MOB-032LC | Mouse Anti-OVR110 Recombinant Antibody (MOB-032LC) | ELISA, FC, IHC | Mouse IgG |
There are currently no Customer reviews or questions for TAB-792CL. Click the button above to contact us or submit your feedback about this product.
View the frequently asked questions answered by Creative Biolabs Support.
For Research Use Only. Not For Clinical Use.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.